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Nadège Droz and Pedro Marques-Vidal*Abstract
Background: Multivitamin/multimineral (MVM) supplements are commonly consumed by the general population,
but little is known regarding their composition and compliance with local regulations. We assessed the
composition and compliance with regulations [no indication in the label of vitamin/minerals amounting <15% of
the acceptable daily intake (ADI)] of MVM available in Switzerland.
Methods: The composition of vitamin/minerals supplements was obtained from the Swiss drug compendium, the
Internet, pharmacies, parapharmacies and supermarkets. MVM was defined as the presence of at least 5 vitamins
and/or minerals.
Results: Of the 254 vitamin/mineral supplements collected, 95 (37%) were considered as MVM. The most frequent
vitamins were B6 (73.7%), C (71.6%), B2 (69.5%) and B1 (67.4%); the least frequent were K (17.9%), biotin (51.6%),
pantothene (55.8%) and E (56.8%). Approximately half of MVMs provided >150% of the ADI for vitamins. The most
frequent minerals were zinc (66.3%), calcium (55.8%), magnesium (54.7%) and copper (48.4%), and the least
frequent were fluoride (3.2%), phosphorous (17.9%), chrome (22.1%) and iodine (25%). More than two thirds of
MVMs provided between 50 and 150% of the ADI for minerals, and few MVMs provided >150% of the ADI. While few
MVMs provided <15% of the ADI for vitamins, a considerable fraction did so for minerals (32.7% for magnesium, 26.1%
for copper and 22.6% for calcium).
Conclusion: There is a great variability regarding the composition of MVMs available in Switzerland. Several MVM do
not comply with Swiss regulations, which calls for monitoring and corrective measures.
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Consumption of multivitamin/mineral (MVM) supple-
ments is popular in the general population [1,2]. In
Switzerland, 16.8% of the population aged between 35 and
75 consume MVM [1]. In the European Union (EU),
MVM represent half of the EU food supplement market,
which has been estimated at around five billion Euros in
2005 [3] and over six billion Euros in 2012 [4]. MVM can
contain a variable number of vitamins and minerals, the
characteristics and amounts ranges of which are regulated
[5,6]. Nevertheless, this regulation is relatively supple, as
no definition of MVM is currently available, and the
amounts of vitamins or minerals allowed per unit (pill,
capsule…) can vary considerably. This leads to a large* Correspondence: Pedro-Manuel.Marques-Vidal@chuv.ch
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less otherwise stated.variety of MVM supplements available, which differ in the
number and amount of vitamins and minerals included.
Hence, comparisons between countries regarding the
prevalence of MVM consumers or the amount of vitamins
and minerals brought by MVM are difficult to perform.
Further, study participants and even nonnutritionist inter-
viewers have been shown to incorrectly identify or record
MVMs, thus making between-study comparisons difficult
[7]. Similarly, shifting from one MVM supplement to an-
other might lead to changes in vitamin and mineral intake,
with possible consequences for health. Indeed, it has been
suggested that the effect of vitamin supplementation
might differ according to the status of other vitamins
[8,9], although other studies failed to show any effect of
MVM on mortality (for a review, see [10]).ed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribu-
ed the original work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article, un-
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ition and compliance with Swiss legislation of the MVM
available in Switzerland.Methods
The composition of vitamin/mineral supplements avail-
able in Switzerland was obtained from several sources: the
Swiss drug compendium, the Internet, pharmacies, para-
pharmacies and supermarkets. Whenever necessary, fur-
ther information was gathered by contacting the producer.
The geographical search area was restricted to the Vaud
canton, but all information in French, German or Italian
(official languages in Switzerland) was collected. The fol-
lowing initial inclusion criteria were used: 1) containing at
least one vitamin/mineral; 2) taken orally and 3) amount
of vitamin/mineral indicated.
Amount of vitamins and minerals provided by the MVMs
For each vitamin/mineral supplement retained, the com-
position and the maximal recommended posology (if
available) were collected. When the recommended posol-
ogy was missing, the value of one unit/day was used. The
percentage of the acceptable daily intake (“apports jour-
naliers admissibles”) provided by the maximum posology
was also calculated and categorized as follows: <15%, 15-
150% and >150%. The ADIs were derived from the Swiss
legislation [5]. According to the Swiss legislation, if a
MVM contains a vitamin or mineral in amounts lower
than 15% or the ADI, this vitamin (mineral) should not be
indicated on the label [5].Statistical analysis
Statistical analyses were conducted using Stata v.12 (Stata
corp, College Station, TX, USA). Descriptive results were
presented as number (percentage) or median [interquartile
range]. As there is no common definition for a multivita-
min preparation, two analyses were performed: the first
considered all supplements with at least 5 vitamins and/or
minerals, and the second included only supplements with
at least 10 vitamins and/or minerals.Results
Of the 254 vitamin/mineral supplements initially retained,
95 (37%) had at least 5 components and were considered
as MVM. Their composition is summarized in Table 1.
The most frequent vitamins were B6, C, B2 and B1, while
vitamins K and A were present in less than half of the
MVMs. The most frequent minerals were zinc, calcium,
magnesium and copper, while fluoride, phosphorous, po-
tassium and chrome were present in less than one quarter
of the MVMs.Amount of vitamins and minerals provided by the MVMs
When the maximum recommended posology was consid-
ered, more than half of the MVMs provided intakes >150%
of the ADI for all vitamins, excepting niacin and vitamin K
(Table 1). Most of the resulting intakes for minerals were
between 15% and 150% of the ADI, although higher per-
centages of MVMs below 15% of ADI were noted for phos-
phorous, magnesium, copper and calcium (Table 1).
Restricting the analysis to MVM with at least 10 ingredi-
ents decreased the number of supplements to 46 (18%)
and led to a slight decrease of the intakes representing
more than 150% of the ADI for vitamins, while no consid-
erable change was found for minerals (Table 2).
Discussion
To our knowledge, this is the first study in Switzerland
and in Europe to assess the composition and compliance
to regulations of MVM. Our results show that the com-
position of MVMs varies considerably according to the
definition applied. For instance, if a loose definition is
used (at least 5 vitamins or minerals), a sizable fraction
of the MVMs lacks specific vitamins or minerals; using a
more restrictive criterion (at least 10 vitamins or min-
erals) leads to products that contain mostly all vitamins
and minerals. Hence, we propose that MVMs be defined
as components that contain at least 10 different vitamins
or minerals, as a first step for standardization and com-
parison between studies. Still, such standardization will
be very difficult to achieve, as current national regula-
tions do not impose a fixed number of components or a
specific amount for each component in MVMs. Further,
even within a single country, there are wide differences
in the definition of MVM, ranging from at least one vita-
min and one mineral plus other ingredients to 3 vita-
mins with or without minerals [7]. Still, and whenever
possible, investigators should indicate which definition
of MVM they use in their study.
Amount of vitamins and minerals provided by the MVMs
Slightly more than half of all MVMs provided vitamins in
amounts exceeding 150% of the ADI, while the percentage
of MVMs providing minerals exceeding the 150% thresh-
old was considerably lower. Interestingly, MVMs with at
least 10 vitamins and minerals appeared to contain lower
doses than MVMs with at least 5 vitamins or minerals.
The reasons for such a discrepancy are unclear and can
only be speculated. Hydrosoluble vitamins consumed in
excess can be excreted via the kidney, while no such mech-
anism is available for some minerals; hence, the amount of
minerals might be reduced for safety reasons. Even though,
water-soluble vitamins in excess can have adverse health
effects. For instance, ascorbic acid supplements have been
associated with a 2-fold increase in the incidence of kidney
stones [11] and can also lead to oxalosis in subjects with
Table 1 Presence of, and percentage of the acceptable daily intake provided by different vitamins and minerals in
multivitamin-multimineral supplements available in Switzerland containing at least 5 components
% of MVM containing Amount§ Median [IQR] % ADI§ Median [IQR] <15% ADI 15-150% ADI >150% ADI
Vitamins
Vitamin A (IE) 34 (35.8) 2667 [1047–3500] 100 [32.5 - 131.2] 4 (11.8) 30 (88.2) -
Vitamin B1 (mg) 64 (67.4) 2.3 [1.4 - 4.5] 205 [127–409] - 30 (46.9) 34 (53.1)
Vitamin B12 (μg) 58 (61.0) 4.5 [2.5 - 10] 180 [100–400] - 26 (44.8) 32 (55.2)
Vitamin B2 (mg) 66 (69.5) 2.2 [1.6 - 4.8] 157 [114–343] - 33 (50.0) 33 (50.0)
Vitamin B6 (mg) 70 (73.7) 3 [2–6] 214 [143–429] - 27 (38.6) 43 (61.4)
Vitamin C (mg) 68 (71.6) 100 [60–240] 125 [75–300] 2 (2.9) 37 (54.3) 29 (42.7)
Vitamin D (μg) 57 (60.0) 10 [5–15] 200 [100–300] - 25 (43.9) 32 (56.1)
Vitamin E (mg) 54 (56.8) 17.5 [10–50] 146 [83–417] - 27 (50.0) 27 (50.0)
Vitamin K (μg) 17 (17.9) 50 [27.5 - 100] 67 [37–133] - 14 (82.3) 3 (17.7)
Niacin (mg) 61 (64.2) 20 [17–47] 125 [106–294] - 37 (60.7) 24 (39.3)
Pantothenic acid (mg) 53 (55.8) 16.2 [6–23.5] 269 [100–392] - 18 (34.0) 35 (66.0)
Folic acid (μg) 56 (59.0) 400 [200–600] 200 [100–300] 1 (1.8) 19 (33.9) 36 (64.3)
Biotin (μg) 49 (51.6) 150 [47.5 - 200] 300 [95–400] 1 (2.0) 20 (40.8) 28 (57.2)
Minerals
Calcium (mg) 53 (55.8) 200 [122.5 - 500] 25 [15–63] 12 (22.6) 37 (69.8) 4 (7.6)
Magnesium (mg) 52 (54.7) 100 [50–187.5] 27 [13–50] 17 (32.7) 33 (63.5) 2 (3.9)
Iron (mg) 39 (41.1) 10 [5.6 - 14] 71 [40–100] 4 (10.3) 30 (76.9) 5 (12.8)
Copper (μg) 46 (48.4) 950 [115–1000] 95 [12–100] 12 (26.1) 27 (58.7) 7 (15.2)
Iodine (μg) 23 (24.2) 150 [75–150] 100 [50–100] 1 (4.3) 20 (87.0) 2 (8.7)
Zinc (mg) 63 (66.3) 10 [7.5 - 15] 100 [75–150] 3 (4.8) 38 (60.3) 22 (34.9)
Manganese (mg) 45 (47.4) 2.0 [1.0 - 3.3] 100 [50–165] 3 (6.7) 29 (64.4) 13 (28.9)
Selenium (μg) 38 (40.0) 50 [27.3 - 70] 91 [50–127] 1 (2.6) 28 (73.7) 9 (23.7)
Chrome (μg) 21 (22.1) 35 [25–50] 88 [63–125] - 18 (85.7) 3 (14.3)
Molybdenum (μg) 22 (23.2) 50 [45–100] 100 [90–200] - 15 (68.2) 7 (31.8)
Fluoride (mg) 3 (3.2) 1.5 [0.4 - 3.5]
Potassium (mg) 21 (22.1) 80 [28–190] 4 [1–10] 16 (76.2) 4 (19.1) 1 (4.8)
Phosphorous (mg) 17 (17.9) 125 [20–142] 18 [3–20] 8 (47.1) 9 (52.9) -
For components containing at least 5 vitamins or minerals (N=95). IQR, interquartile range; MVM, multivitamin/multimineral; ADI, acceptable daily intake according
to the Swiss legislation. Results are expressed as number of products (percentage) or as median [interquartile range]. §for maximum recommended posology;
when the posology was not available, a value of 1unit/day was considered. No ADI available for fluoride.
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number of vitamins and minerals might be more expensive,
thus tempting the manufacturers to reduce the amount of
vitamins and minerals present per unit. Still, further
research is needed to clarify this issue.
The main iodine source in Switzerland is iodized table
salt, which has proved a successful preventive measure
against goiter and iodine deficiency [13,14]. Still, recom-
mendations towards lower salt intake [15] and the use of
fashionable, exotic (and non-iodized) salt by the Swiss
population might actually lead to an increase in iodine
deficiency [16]. Somewhat unexpectedly, the number of
MVMs containing iodine was rather low, while it could beof benefit for a fraction of the Swiss population. Indeed,
MVM consumers tend to pursue a healthier dietary pat-
tern and to be more respondent to dietary recommenda-
tions, including salt reduction. Hence, in these subjects,
the lower iodine intake due to lower salt intake could be
compensated by MVMs.
Vitamin K, a major determinant of blood coagulation,
was present in one out of six MVMs and in one out of
three if the threshold of at least 10 vitamins or minerals
was used. Importantly, vitamin K was mainly indicated for
prevention against arthritis, and no information regarding
its effect on coagulation or its interaction with oral antico-
agulants was found. This lack of information can have
Table 2 Presence of, and percentage of the acceptable daily intake provided by different vitamins and minerals in
multivitamin-multimineral supplements available in Switzerland containing at least 10 components
% of MVM containing Amount§ Median [IQR] % ADI§ Median [IQR] <15% ADI 15-150% ADI >150% ADI
Vitamins
Vitamin A (IE) 29 (63.0) 2667 [1739–3550] 100 [50–131] 1 (3.5) 28 (96.6) -
Vitamin B1 (mg) 44 (95.7) 1.5 [1.4 - 4.2] 136 [127–377] - 27 (61.4) 17 (38.6)
Vitamin B12 (μg) 42 (91.3) 3.5 [2.0 - 8.1] 140 [78–325] - 21 (50.0) 21 (50.0)
Vitamin B2 (mg) 44 (95.7) 1.7 [1.5 - 4.1] 121 [104–293] - 28 (63.6) 16 (36.4)
Vitamin B6 (mg) 46 (100.0) 2.6 [2.0 - 5.2] 186 [143–368] - 22 (47.8) 24 (52.2)
Vitamin C (mg) 44 (95.7) 90 [60–180] 112.5 [75–225] - 28 (63.6) 16 (36.4)
Vitamin D (μg) 39 (84.8) 5.5 [5.0 - 12.5] 110 [100–250] - 20 (51.3) 19 (48.7)
Vitamin E (mg) 41 (89.1) 15 [10.0 - 36.7] 125 [83–305] - 22 (53.7) 19 (46.3)
Vitamin K (μg) 15 (32.6) 50 [25–75] 67 [33–100] - 14 (93.3) 1 (6.7)
Niacin (mg) 44 (95.7) 18 [16–30] 113 [100–188] - 31 (70.5) 13 (29.6)
Pantothenic acid (mg) 38 (82.6) 10 [6–20] 167 [100–333] - 16 (42.1) 22 (57.9)
Folic acid (μg) 41 (89.1) 400 [200–407] 200 [100–204] - 14 (34.2) 27 (65.9)
Biotin (μg) 39 (84.8) 75 [40–200] 150 [80–400] - 18 (46.2) 21 (53.9)
Minerals
Calcium (mg) 33 (71.4) 180.6 [100–239] 23 [13–30] 9 (27.3) 24 (72.7) -
Magnesium (mg) 35 (76.1) 60 [40–100] 16 [11–27] 17 (48.6) 18 (51.4) -
Iron (mg) 30 (65.2) 10 [7–15] 71 [50–107] 2 (6.7) 24 (80.0) 4 (13.3)
Copper (μg) 30 (65.2) 900 [367.5 - 1000] 90 [37–100] 7 (23.3) 20 (66.7) 3 (10.0)
Iodine (μg) 22 (47.8) 150 [71.3 - 150] 100 [48–100] 1 (4.6) 19 (86.4) 2 (9.1)
Zinc (mg) 41 (89.1) 10 [6.8 - 15] 100 [68–150] 3 (7.3) 27 (65.9) 11 (26.8)
Manganese (mg) 31 (67.4) 2 [1–3] 100 [50–150] 2 (6.5) 21 (67.7) 8 (25.8)
Selenium (μg) 25 (54.4) 50 [26.5 - 57.5] 91 [48–105] 1 (4.0) 19 (76.0) 5 (20.0)
Chrome (μg) 19 (41.3) 35 [25–50] 88 [63–125] - 16 (84.2) 3 (15.8)
Molybdenum (μg) 21 (45.7) 50 [45–100] 100 [90–200] - 14 (66.7) 7 (33.3)
Fluoride (mg) 3 (6.5) 1.5 [0.4 - 3.5]
Potassium (mg) 12 (26.1) 80 [22–80] 4 [1–4] 11 (91.7) 1 (8.3) -
Phosphorous (mg) 15 (32.6) 50 [20–133.3] 7 [3–19] 8 (53.3) 7 (46.7) -
For components containing at least 10 vitamins or minerals (N=46). IQR, interquartile range; MVM, multivitamin/multimineral; ADI, acceptable daily intake
according to the Swiss legislation. Results are expressed as number of products (percentage) or as median [interquartile range]. §for maximum recommended
posology; when the posology was not available, a value of 1/day was considered.
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content of vitamin K exceeds 150% of the ADI. For in-
stance, elderly people presenting with arthritis (and some
of which on oral anticoagulants) might be tempted to
consume MVM containing vitamin K, thus modifying
their coagulation status and ultimately their health [17].
Although most patients on oral anticoagulants are aware
of the need to check their sources of vitamin K, still many
believe that MVM are equivalent and might compromise
their treatment when shifting from one brand of MVM to
another. Finally, very few MVMs contained fluoride, prob-
ably in order to prevent any adverse effect of excessive
consumption [18].Compliance with national regulations
Several MVMs indicated in their label vitamins or
minerals in amounts lower than 15% of the ADI. These
MVM do not comply with Swiss regulations, which
indicate that if a MVM contains a vitamin (mineral) in
amounts lower than 15% or the ADI, this vitamin
(mineral) should not be stated on the label [5]. Inad-
equate labeling concerned mainly calcium, magnesium
and copper, while very few vitamins had values below
the 15% level. Marketing issues might explain this find-
ing, as MVMs with calcium and magnesium indicated
in the label might be more appealing to the elderly (as
prevention for osteoporosis) and to subjects with
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needed to better assess this point.
Study strengths and limitations
Our study provides important information for epidemi-
ologic studies investigating the association between
MVM and chronic diseases and also for communicating
results from such studies to the general public. The
considerable variation in doses and included vitamins
and minerals in MVM observed makes it hard to ad-
equately measure exposure to MVMs and to compare
studies assessing MVM use.
This study has also several limitations that should be
accounted for. First, the collection of vitamin and mineral
supplements was limited to the canton of Vaud, and it is
possible that other products are available in other cantons.
Still, all vitamin supplements from the Swiss drug com-
pendium and from national producers and sellers were
collected, which might limit the number of supplements
missed. Second, there is no standard definition of MVM,
so the results and conclusions might change if other defi-
nitions are proposed. Thus, a minimal standardization of
the definition of MVM is needed, which will allow com-
paring between studies. Third, it was not possible to valid-
ate the vitamin and mineral content of the MVM, due to
the lack of funding. It will be of interest that the Swiss
agency for therapeutic products performs such controls, at
least in a limited sample of MVMs. Fourth, some MVMs
had no posology indicated. Thus, a maximal posology of
one unit per day was considered, as it was the most
frequently recommended.
Conclusion
Multivitamin/multimineral supplements available in
Switzerland vary considerably regarding their composition
and amount of vitamins and minerals. Several MVM do
not comply with the Swiss regulations, which calls for
monitoring and corrective measures.
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